Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study
Our research indicated that although patients on HCQ had a higher prevalence of PH, they exhibited lower mortality rates, suggesting a possible survival benefit. Further prospective studies are needed to explore these findings and clarify HCQ's role in SSC management.
Authors
- Rafal Ali
- Naveen Gautam (ORCID: https://orcid.org/0000-0001-6291-333X)
- Bal Krishna Subedi (ORCID: https://orcid.org/0009-0005-7170-9951)
- Irene Tan (ORCID: https://orcid.org/0000-0001-8572-7353)
Institutions
- Pennsylvania Hospital (US)
- Gumi University (KR)
- Jefferson Hospital (US)
- Einstein Medical Center Montgomery (US)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/1756-185x.70515
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00